Cargando…
Effects of a Secondary Prevention Combination Therapy with beta-Blocker and Statin on Major Adverse Cardiovascular Events in Acute Coronary Syndrome Patients
BACKGROUND: The efficacy of a beta-blocker or statin alone versus combination therapy is uncertain. We compared the effects of a combination of beta-blocker and statin with those of one-drug therapies with regard to the occurrence of a major adverse cardiovascular event (MACE) in patients with acute...
Autores principales: | Zhu, Ling, Cui, Qianwei, Liu, Ying, Liu, Zhongwei, Zhang, Yong, Liu, Fuqiang, Wang, Junkui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453752/ https://www.ncbi.nlm.nih.gov/pubmed/32808600 http://dx.doi.org/10.12659/MSM.925114 |
Ejemplares similares
-
Higher baseline lipid levels amplify the benefit of secondary prevention therapy with statins in Chinese patients with acute coronary syndrome
por: Zhu, Ling, et al.
Publicado: (2020) -
Impact of Plasma Exposure of Statins and Their Metabolites With Major Adverse Cardiovascular Events in Chinese Patients With Coronary Artery Disease
por: Zhou, Xiao-hong, et al.
Publicado: (2020) -
Effect of Statins on Major Adverse Cardiovascular Events in Patients with Coronary Artery Spasm: A Meta-Analysis of the Asia Region
por: Zhao, Tian-Jun, et al.
Publicado: (2023) -
Equity in the use of antithrombotic drugs, beta-blockers and statins among Finnish coronary patients
por: Manderbacka, Kristiina, et al.
Publicado: (2008) -
Sex-Specific Associations of Anxiety With Left Ventricular Hypertrophy and Transmural Dispersion of Repolarization in Hypertensive Patients
por: Zhu, Ling, et al.
Publicado: (2022)